Diagnostic Healthcare receives £1m from biomedical fund

North West Fund for Biomedical grant will expand diagnostic services and medical equipment portfolio

Diagnostic Healthcare has secured £1m worth of investment from The North West Fund for Biomedical to expand its diagnostic services, increase community services across the country, and expand its portfolio of medical equipment.

Headquartered in Altrincham, the company has a network of centres and mobile units across the UK providing MRI scans, obstetric ultrasound, bone density scans (DEXA scan), cardiac testing, health screening and reporting services.

The cash comes from the The North West Fund for Biomedical, managed by SPARK Impact, which is part of the wider £155m North West Fund, financed jointly by the European Regional Development Fund and the European Investment Bank.

Liat Karni, managing director of Diagnostic Healthcare, said: “This investment will support the ongoing growth of the company and will enable us to provide more high-end diagnostic services in more locations across the UK, as well as expanding our leading range of medical equipment.”

Dr Penny Attridge, senior investment director at SPARK Impact and manager of The North West Fund for Biomedical, added: “The range of services being provided by Diagnostic Healthcare could make a significant impact on the provision of diagnostic imaging in the UK and abroad. We are delighted to make this investment in a high-quality service which is an asset to the North West and to SPARK’s biomedical portfolio.”

Diagnostic Healthcare is The North West Fund for Biomedical’s 34th investment to date.

Companies